248 related articles for article (PubMed ID: 1477607)
1. The levels of vascular smooth as well as skeletal muscle actin mRNAs differ substantially among both myoblast and fibroblast lines with different skeletal myogenic potentials.
Sharp SB; Vazquez A; Theimer M; Silva DK; Muscati SR; Sylber M; Mogassa M
Cell Mol Biol (Noisy-le-grand); 1992 Dec; 38(8):903-13. PubMed ID: 1477607
[TBL] [Abstract][Full Text] [Related]
2. The levels of vascular smooth as well as skeletal muscle actin mRNAS differ substantially among both myoblast and fibroblast lines with different skeletal myogenic potentials.
Sharp SB; Vazquez A; Theimer M; Silva DK; Muscati SR; Sylber M; Mogassa M
Cell Mol Biol; 1992 Aug; 38(5):485-504. PubMed ID: 1468109
[TBL] [Abstract][Full Text] [Related]
3. Proteoglycan biosynthesis is required in BC3H1 myogenic cells for modulation of vascular smooth muscle alpha-actin gene expression in response to microenvironmental signals.
Lee SH; Yan H; Reeser JC; Dillman JM; Strauch AR
J Cell Physiol; 1995 Jul; 164(1):172-86. PubMed ID: 7790390
[TBL] [Abstract][Full Text] [Related]
4. Density-dependent modulation of vascular smooth muscle alpha-actin biosynthetic processing in differentiated BC3H1 myogenic cells.
Strauch AR; Min B; Reeser JC; Yan H; Foster DN; Berman MD
J Cell Biochem; 1992 Nov; 50(3):266-78. PubMed ID: 1469063
[TBL] [Abstract][Full Text] [Related]
5. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development.
Haider SR; Wang W; Kaufman SJ
Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852
[TBL] [Abstract][Full Text] [Related]
6. [Early stages of myogenesis as seen through the action of the myf-5 gene].
Buckingham M
C R Seances Soc Biol Fil; 1997; 191(1):43-54. PubMed ID: 9181127
[TBL] [Abstract][Full Text] [Related]
7. The consequences of a constitutive expression of MyoD1 in ES cells and mouse embryos.
Shani M; Faerman A; Emerson CP; Pearson-White S; Dekel I; Magal Y
Symp Soc Exp Biol; 1992; 46():19-36. PubMed ID: 1341036
[TBL] [Abstract][Full Text] [Related]
8. Conditional conversion of ES cells to skeletal muscle by an exogenous MyoD1 gene.
Dekel I; Magal Y; Pearson-White S; Emerson CP; Shani M
New Biol; 1992 Mar; 4(3):217-24. PubMed ID: 1581290
[TBL] [Abstract][Full Text] [Related]
9. Substrate-associated macromolecules promote cytodifferentiation of BC3H1 myogenic cells.
Strauch AR; Berman MD; Miller HR
J Cell Physiol; 1991 Mar; 146(3):337-48. PubMed ID: 1708777
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of BMP4 on NIH/3T3 and C2C12 cells: implications for endochondral bone formation.
Li G; Peng H; Corsi K; Usas A; Olshanski A; Huard J
J Bone Miner Res; 2005 Sep; 20(9):1611-23. PubMed ID: 16059633
[TBL] [Abstract][Full Text] [Related]
11. Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis.
Rawls A; Morris JH; Rudnicki M; Braun T; Arnold HH; Klein WH; Olson EN
Dev Biol; 1995 Nov; 172(1):37-50. PubMed ID: 7589813
[TBL] [Abstract][Full Text] [Related]
12. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents.
Rohwedel J; Maltsev V; Bober E; Arnold HH; Hescheler J; Wobus AM
Dev Biol; 1994 Jul; 164(1):87-101. PubMed ID: 8026639
[TBL] [Abstract][Full Text] [Related]
13. Expression of myogenic regulatory factors during muscle development of Xenopus: myogenin mRNA accumulation is limited strictly to secondary myogenesis.
Nicolas N; Gallien CL; Chanoine C
Dev Dyn; 1998 Nov; 213(3):309-21. PubMed ID: 9825866
[TBL] [Abstract][Full Text] [Related]
14. Targeted inactivation of myogenic factor genes reveals their role during mouse myogenesis: a review.
Arnold HH; Braun T
Int J Dev Biol; 1996 Feb; 40(1):345-53. PubMed ID: 8735947
[TBL] [Abstract][Full Text] [Related]
15. Stau1 negatively regulates myogenic differentiation in C2C12 cells.
Yamaguchi Y; Oohinata R; Naiki T; Irie K
Genes Cells; 2008 Jun; 13(6):583-92. PubMed ID: 18422603
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro.
Muñoz-Cánoves P; Miralles F; Baiget M; Félez J
Thromb Haemost; 1997 Mar; 77(3):526-34. PubMed ID: 9066006
[TBL] [Abstract][Full Text] [Related]
17. Colocalization of bFGF and the myogenic regulatory gene myogenin in dystrophic mdx muscle precursors and young myotubes in vivo.
Garrett KL; Anderson JE
Dev Biol; 1995 Jun; 169(2):596-608. PubMed ID: 7781901
[TBL] [Abstract][Full Text] [Related]
18. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells.
Cornelison DD; Wold BJ
Dev Biol; 1997 Nov; 191(2):270-83. PubMed ID: 9398440
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo tetracycline-controlled myogenic conversion of NIH-3T3 cells: evidence of programmed cell death after muscle cell transplantation.
Del Bo R; Torrente Y; Corti S; D'Angelo MG; Comi GP; Fagiolari G; Salani S; Cova A; Pisati F; Moggio M; Ausenda C; Scarlato G; Bresolin N
Cell Transplant; 2001; 10(2):209-21. PubMed ID: 11332636
[TBL] [Abstract][Full Text] [Related]
20. Expression of muscle genes in the mouse embryo.
Buckingham M; Houzelstein D; Lyons G; Ontell M; Ott MO; Sassoon D
Symp Soc Exp Biol; 1992; 46():203-17. PubMed ID: 1341037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
